Clinical Trials Browser

Phase 1 × Neoplasms, Plasma Cell × Surveys and Questionnaires × Clear all

NCT01440582 2019-03-04

Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01807286 2016-05-13

Pomalidomide With Melphalan and Dexamethasone for Untreated Systemic AL Amyloidosis

Phase 1 Terminated

Amyloidosis, Neoplasms, Plasma Cell